Latham Advises NextGen Healthcare on US$230 Million Convertible Senior Notes Offering

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, has announced the pricing of its offering of US$230,000,000 aggregate principal amount of 3.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933. The offering size was increased from the previously announced offering size of US$200,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on November 1, 2022, subject to customary closing conditions. NextGen Healthcare also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional US$45,000,000 principal amount of notes.

Latham & Watkins LLP represents NextGen Healthcare in the offering with a corporate deal team led by New York/Los Angeles partner Greg Rodgers and Orange County partner Michael Treska, with New York associates Sara Johnson, Darby Dietrich, and Yulong Li. Advice was also provided on convertible debt matters by Los Angeles partner Arash Aminian Baghai, with New York associate Ryan Gold and Los Angeles associate Andrew Bentz; and on tax matters by New York partners Elena Romanova and Bora Bozkurt, with New York associate Jacob Nagelberg.